The serum levels of IL-17, IL-10, hs-CRP, and TNF-α were determined to evaluate the production of inflammatory cytokines in NAFLD patients after treatment with DHZCPs. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.